Long-term follow-up result of antithyroid drug treatment of Graves’ hyperthyroidism in a large cohort

医学 抗甲状腺药物 格雷夫斯病 抗甲状腺药 药品 队列 期限(时间) 儿科 丙基硫氧嘧啶 内科学 内分泌学 药理学 甲状腺 物理 量子力学
作者
Meihua Jin,Ahreum Jang,Chae A Kim,Tae Yong Kim,Won Bae Kim,Young Kee Shong,Min Ji Jeon,Won Gu Kim
出处
期刊:European thyroid journal [Karger Publishers]
卷期号:12 (2) 被引量:28
标识
DOI:10.1530/etj-22-0226
摘要

Objective: This study evaluated the efficacy of antithyroid drugs (ATDs) and risk factors associated with the recurrence of Graves' hyperthyroidism using a comprehensive retrospective cohort. Methods: We included 1829 patients newly diagnosed with Graves' hyperthyroidism, with sufficient follow-up data. Clinical outcomes of the patients and risk factors associated with recurrence-free survival, including the changes in thyrotropin receptor antibody, were evaluated. Results: The median age of the patients was 44.5 years, and 69% were female. Among the patients, 1235 had a chance to withdraw ATD after a median of 23 (interquartile range (IQR) 17.0-35.5) months of treatment. The first remission rate was 55.6% during a median of 72.7 months of follow-up. After the first recurrence, 95% of patients underwent the second course of ATD treatment for a median of 21.1 (IQR 14.8-31.7) months, and the remission rate was 54.1%. During a median of 67 months of follow-up, 7.7% of patients underwent surgery, and 10.5% underwent radioactive iodine therapy. Approximately 30% were still on ATD therapy for recurrent disease or prolonged low-dose maintenance. Younger age (<45 years), male sex, and fluctuating or smoldering of TRAb levels were independent risk factors of the first recurrence after ATD treatment. Conclusions: ATD treatment is an acceptable option for the initial treatment of Graves' hyperthyroidism as well as for recurrent disease. The optimal treatment period for ATD treatment needs to be determined using the individual risk factors of recurrence.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
刚刚
1秒前
1秒前
1秒前
molihuakai的应助被小巧秋天采纳,获得10
1秒前
DaSheng发布了新的文献求助10
2秒前
2秒前
2秒前
zhenghangbin发布了新的文献求助10
2秒前
2秒前
Orange的应助被qqh采纳,获得10
3秒前
小荣同学完成签到 ,获得积分10
4秒前
4秒前
zhenghangbin发布了新的文献求助10
5秒前
清秀语蝶的应助被ku采纳,获得20
5秒前
CBY完成签到,获得积分10
5秒前
桔桔桔发布了新的文献求助10
5秒前
5秒前
完美世界的应助被小强采纳,获得10
6秒前
6秒前
路明非完成签到,获得积分10
6秒前
7秒前
风晓博发布了新的文献求助10
7秒前
fat发布了新的文献求助10
7秒前
zhenghangbin发布了新的文献求助10
7秒前
7秒前
笨笨西装发布了新的文献求助10
7秒前
蓝色山楂蘑菇完成签到 ,获得积分10
7秒前
zezeze发布了新的文献求助10
8秒前
8秒前
9秒前
小杨肉串发布了新的文献求助10
9秒前
蓝天发布了新的文献求助10
10秒前
zhenghangbin发布了新的文献求助10
10秒前
顾芷萌完成签到,获得积分10
10秒前
10秒前
CodeCraft的应助被可爱的又菡采纳,获得10
12秒前
12秒前
12秒前
zhenghangbin发布了新的文献求助10
12秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
八旗制度の研究 600
plantTFDB 508
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8177849
求助须知:如何正确求助?哪些是违规求助? 9568641
关于积分的说明 21800145
捐赠科研通 7772473
什么是DOI,文献DOI怎么找? 3432537
关于科研通互助平台的介绍 2556720
邀请新用户注册赠送积分活动 2478067